Response to Neoadjuvant Systemic Therapy May Serve as an Indicator for Omitting Post-BCS Radiation Therapy in Women with Early-Stage Breast Cancer
Post-BCS RT can be omitted for women with early-stage breast cancer who achieved CR to NST. For those who failed to achieve CR to NST, a nomogram was constructed for clinicians to decide whether to omit post-BCS RT or not based on the individualized assessment.
Authors
- Chong Du (ORCID: https://orcid.org/0000-0002-2105-3078)
- Jingkun Qu (ORCID: https://orcid.org/0000-0002-5064-2832)
- Mengjie Liu (ORCID: https://orcid.org/0000-0002-3932-3363)
- Shuqun Zhang (ORCID: https://orcid.org/0000-0003-2959-6461)
- Yiwei Jia (ORCID: https://orcid.org/0000-0001-5089-3941)
- Yusheng Wang (ORCID: https://orcid.org/0000-0002-8168-6395)
- Chaofan Li (ORCID: https://orcid.org/0000-0002-5426-1498)
- Shiyu Sun (ORCID: https://orcid.org/0000-0002-4036-8921)
Institutions
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Cancer Research and Treatment
- Published
- 2025-09-10
- DOI
- https://doi.org/10.4143/crt.2025.584
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- National Natural Science Foundation of China
- Key Research and Development Projects of Shaanxi Province